|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/01/16 Orthofix Medical Inc. 10-Q 6/30/16 56:5.6M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 488K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
11: R1 Document and Entity Information HTML 39K
12: R2 Condensed Consolidated Balance Sheets HTML 89K
13: R3 Condensed Consolidated Balance Sheets HTML 30K
(Parenthetical)
14: R4 Condensed Consolidated Statements of Operations HTML 133K
and Comprehensive Income (Loss)
15: R5 Condensed Consolidated Statements of Cash Flows HTML 62K
16: R6 Nature of operations, basis of presentation and HTML 32K
recently issues accounting pronouncements
17: R7 Inventories HTML 46K
18: R8 Long-term debt HTML 23K
19: R9 Derivative instruments HTML 68K
20: R10 Fair value measurements HTML 180K
21: R11 Accumulated other comprehensive loss HTML 71K
22: R12 Earnings per share HTML 58K
23: R13 Share-based compensation HTML 26K
24: R14 Income taxes HTML 25K
25: R15 Business segment information HTML 207K
26: R16 Contingencies HTML 48K
27: R17 Share repurchase plan HTML 22K
28: R18 Nature of operations, basis of presentation and HTML 32K
recently issues accounting pronouncements
(Policies)
29: R19 Inventories (Tables) HTML 46K
30: R20 Derivative instruments (Tables) HTML 65K
31: R21 Fair value measurements (Tables) HTML 172K
32: R22 Accumulated other comprehensive loss (Tables) HTML 67K
33: R23 Earnings per share (Tables) HTML 55K
34: R24 Business segment information (Tables) HTML 203K
35: R25 Nature of operations, basis of presentation and HTML 21K
recently issues accounting pronouncements -
Additional Information (Detail)
36: R26 Inventories - Schedule of Inventories (Detail) HTML 31K
37: R27 Long-Term Debt - Additional Information (Detail) HTML 35K
38: R28 Derivative Instruments - Schedule of Fair Values HTML 28K
of Derivative Instruments (Detail)
39: R29 Derivative Instruments - Schedule of Gain (Loss) HTML 25K
Recognized in Other Comprehensive Income (Loss)
(Detail)
40: R30 Fair Value Measurements - Schedule of Financial HTML 53K
Assets and Liabilities Measured at Fair Value on
Recurring Basis (Detail)
41: R31 Fair Value Measurements - Additional Information HTML 42K
(Detail)
42: R32 Fair Value Measurements - Schedule of HTML 28K
Reconciliation of Debt Securities (Detail)
43: R33 Accumulated Other Comprehensive Loss - Components HTML 46K
of Changes in Accumulated Other Comprehensive Loss
(Detail)
44: R34 Accumulated Other Comprehensive Loss - Components HTML 35K
of Changes in Accumulated Other Comprehensive Loss
(Parenthetical) (Detail)
45: R35 Earnings Per Share - Schedule of Reconciliation of HTML 29K
Weighted Average Shares Used in Calculation of
Basic and Diluted Net (Loss) Income Per Share
(Detail)
46: R36 Earnings Per Share - Additional Information HTML 28K
(Detail)
47: R37 Share-based Compensation - Additional Information HTML 31K
(Detail)
48: R38 Income Taxes - Additional Information (Detail) HTML 27K
49: R39 Business Segment Information - Additional HTML 20K
Information (Detail)
50: R40 Business Segment Information - Schedule of Net HTML 34K
Sales by SBU Reporting Segment (Detail)
51: R41 Business Segment Information - Summary of Net HTML 53K
Margin as Gross Profit Less Sales and Marketing
Expense by SBU Reporting Segment (Detail)
52: R42 Contingencies - Additional Information (Detail) HTML 41K
53: R43 Share Repurchase Plan - Additional Information HTML 34K
(Detail)
55: XML IDEA XML File -- Filing Summary XML 99K
54: EXCEL IDEA Workbook of Financial Reports XLSX 50K
5: EX-101.INS XBRL Instance -- ofix-20160630 XML 1.55M
7: EX-101.CAL XBRL Calculations -- ofix-20160630_cal XML 116K
8: EX-101.DEF XBRL Definitions -- ofix-20160630_def XML 272K
9: EX-101.LAB XBRL Labels -- ofix-20160630_lab XML 639K
10: EX-101.PRE XBRL Presentations -- ofix-20160630_pre XML 492K
6: EX-101.SCH XBRL Schema -- ofix-20160630 XSD 104K
56: ZIP XBRL Zipped Folder -- 0001564590-16-021905-xbrl Zip 94K
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Orthofix International N.V. (“Orthofix”) on Form 10-Q for the quarterly period ended June 30, 2016, (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, Bradley R. Mason, Chief Executive Officer and President of Orthofix, and Doug Rice, Chief Financial Officer, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:
|
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Orthofix. |
|
Dated: August 1, 2016 |
/s/ BRADLEY R. MASON |
|
|
|
Name: |
|
|
|
Title: |
President and Chief Executive Officer |
|
|
|
|
|
Dated: August 1, 2016 |
/s/ DOUG RICE |
|
|
|
Name: |
|
|
|
Title: |
Chief Financial Officer |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/1/16 | 8-K | ||
| For Period end: | 6/30/16 | |||
| List all Filings | ||||